Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report

17th December 2018 Uncategorised 0

Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer health. And word is Japan’s Taisho will be the one to help the company do it.

More: Bristol-Myers Squibb nears .6B sale of OTC unit Upsa to Taisho: report
Source: fierce